Atopic Dermatitis Research Network Clinical Research Centers

The Atopic Dermatitis Research Network – Clinical Research Centers grant opportunity is a forthcoming initiative from the National Institute of Allergy and Infectious Diseases (NIAID), a key component of the National Institutes of Health (NIH). As part of the U.S. Department of Health and Human Services, NIAID supports research that seeks to understand, treat, and prevent infectious, immunologic, and allergic diseases. This particular program represents NIAID’s commitment to advancing knowledge of atopic dermatitis (AD), a chronic skin condition marked by inflammation and compromised skin barrier function. The primary objective of this funding opportunity is to support a network of U.S.-based clinical research centers that will contribute to the Atopic Dermatitis Research Network (ADRN). The program promotes interdisciplinary and translational research to deepen understanding of skin immunology and defense mechanisms. Projects will investigate the immunological, structural, and functional differences between individuals affected by atopic dermatitis and healthy individuals. This includes both mechanistic studies and pilot trials or observational studies conducted at individual research sites. In addition to clinical investigations, the program emphasizes career development opportunities for junior investigators. Through funded participation in ADRN activities, these individuals can enhance their research expertise and progress toward independence in the field of dermatological immunology. The research centers will be expected to collaborate within the network and contribute to a shared scientific agenda. The cooperative agreement funding mechanism reflects a high level of programmatic involvement from NIAID, ensuring that funded projects align with national research priorities. The forecasted total program funding is approximately $4.52 million, with up to four awards anticipated. While specific award amounts are not yet provided, applicants can expect competitive funding to support comprehensive clinical research programs. No cost sharing or matching is required for applicants. The award and project start dates are both projected for March 1, 2027, allowing significant lead time for proposal development and planning. Eligible applicants include a broad spectrum of organizations such as public and private higher education institutions, nonprofits (with or without 501(c)(3) status), tribal and local governments, public housing authorities, small and other for-profit businesses, regional and community-based organizations, as well as foreign institutions. The opportunity will open for applications around February 27, 2026, with submissions due by May 29, 2026. Interested applicants should monitor Grants.gov and NIH platforms for the formal Notice of Funding Opportunity (NOFO) and submission instructions. For additional information or early inquiries, applicants may contact Michael Minnicozzi, Ph.D., at 301-240-3532 or via email at minnicozzim@niaid.nih.gov. This forecast indicates NIAID’s intent to provide long-term support for AD research and continue building scientific capacity in skin disease and immunology.